Cytiva
Cytiva is the global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. We have a rich heritage tracing back hundreds of years, and a fresh beginning since 2020.
Contactinformatie
- Website:
- www.cytivalifesciences.com
PartnerbijdragenDeveloping a fit-for-purpose bioprocess film
There’s a lot of pressure on single-use systems, both in terms of function and material supply. At Cytiva, one of the ways we’ve addressed this pressure is the development of Fortem™ film — designed specifically for single-use bioprocessing applications.
PartnerbijdragenCytiva launches first formulation system to enable end-to-end clinical and commercial manufacturing of lipid nanoparticle medicines
NanoAssemblr Source: Cytiva NanoAssemblr combines scalable mixing technology to deliver seamless formulation of lipid nanoparticle medicines from clinical development to large-scale commercial manufacturing. Single-use fluid path reduces the risk of cross-contamination, supports efficient changeover between batches and facilitates multi-process workflows to accelerate time to market.
PartnerbijdragenIncreasing process efficiency with X-platform bioreactors by Cytiva
Global biotechnology leader builds on Xcellerex heritage to now offer X-platform bioreactors. X-platform bioreactors can be used for monoclonal antibodies (mAbs), protein-based drugs which continue to give rise to new treatments, as well as manufacturing cell and gene therapies and viral vectors.
PartnerbijdragenFit for Purpose AAV Purification
Realizing the Perfect Scale for Cell and Gene Therapies.
PartnerbijdragenNext steps in automated perfusion
Cytiva has introduced an innovation that supports the biotech industry’s move to continuous manufacturing.
PartnerbijdragenRapid, high-productivity purification of adeno-associated virus
Cytiva’s Fibro technology, known for its increased throughput and productivity in monoclonal antibody purification, is being extended to capture adeno-associated virus (AAV).
- Partnerbijdragen
The gains of automated perfusion
Cytiva has introduced an innovation that supports the biotech industry’s move to continuous manufacturing. Called the Xcellerex Automated Perfusion System (APS), it simplifies processes and reduces risk when intensifying upstream operations.